Bennetts Road South
Keresley
Coventry
CV6 2FL
Why choose us?
Competitive prices
Procedures carried out by fully qualified friendly GP
Comfortable and new surroundings
Convenient treatment times
High client return rate
FREE no obligation consultation
After treatment follow up
Dr Jerry Horn is:
A member of the RCGP
An associate member of BACD
GMC registered
Click the image to find out more about Restylane Dermal filler
Click the image to find out more information about Restylane
Keep visiting the knowledge area as we will continue to develop this page
Another use for Botox – it stops you sweating - more >
Excessive perspirers are having their sweat glands turned off with injections of Botox, according to a cosmetic surgery company, The Harley Medical Group. It says the number of patients receiving the "sweatox" injections has trebled in the past three months and now makes up 31 per cent of its treatments involving Botox, more commonly used to smooth wrinkles.
Read the full article on the Independent website
. Topical toxin gels progress well in trials
Two American companies have two skin products in development that contain botulininum toxin A. These two products, currently known as RT1001 and Cosmetox, are being trialled at the moment and early results sound to be encouraging. The cream has been used in the crow’s feet area, and four weeks after treatment 85% of subjects in one trial reported at least 75% improvement.
Whilst it sounds to be some time away from being marketed in the UK, it could potentially provide an alternative type of treatment for needle-phobic people, and also may help prolong the action of injected botox. There doesn’t appear to have been any trials comparing its results with those of injected botox yet.
(Extracted from Body Language Issue 35 – September/October 2009)
More men opt for cosmetic procedures
A survey by the “American Society for Dermatologic Surgery” reveals a marked increase in the number of men having cosmetic procedures between 2001 and 2007. The use of botox injections has risen by 324%.
(Extracted from Body Language Issue 35 – September/October 2009)
Botulinum neurotoxin-A for treatment of refactory neck pain: a randomised double blind, placebo-controlled study.
Placebo-controlled means that half of the people in the study received injections with no active medication in, and the other half received active medication ,i.e.botox. Double blind means that both subject and doctor didn’t know who received placebo or botox.
The study showed a significant reduction in the pain scores in the botox group, which is encouraging for the future treatment of such people. However, the authors do emphasise that injections should only be done be people properly trained in the technique. Doses of botox used were between 150 and 300 units per subject.
(Extracted from Body Language Issue 35 – September/October 2009)